The patients that were included had prodromal, mild, or moderate AD categorized by MMSE, FCSRT-IR, and CDR as well as amyloid plaques with or without tau pathology on 18F-flortaucipir PET scan. This evidence concerns the gene MAPT and Alzheimer disease.